{Reference Type}: Journal Article
{Title}: Block copolymer micelles as ocular drug delivery systems.
{Author}: Assiri AA;Glover K;Mishra D;Waite D;Vora LK;Thakur RRS;
{Journal}: Drug Discov Today
{Volume}: 29
{Issue}: 8
{Year}: 2024 Aug 10
{Factor}: 8.369
{DOI}: 10.1016/j.drudis.2024.104098
{Abstract}: Block copolymer micelles, formed by the self-assembly of amphiphilic polymers, address formulation challenges, such as poor drug solubility and permeability. These micelles offer advantages including a smaller size, easier preparation, sterilization, and superior solubilization, compared with other nanocarriers. Preclinical studies have shown promising results, advancing them toward clinical trials. Their mucoadhesive properties enhance and prolong contact with the ocular surface, and their small size allows deeper penetration through tissues, such as the cornea. Additionally, copolymeric micelles improve the solubility and stability of hydrophobic drugs, sustain drug release, and allow for surface modifications to enhance biocompatibility. Despite these benefits, long-term stability remains a challenge. In this review, we highlight the preclinical performance, structural frameworks, preparation techniques, physicochemical properties, current developments, and prospects of block copolymer micelles as ocular drug delivery systems.